Publications

Publications pour l'équipe Oncostat

Titre Publication Type Publication year Auteur
Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial journalArticle 2015 Le Tourneau, C.; Delord, J. P.; Goncalves, A.; Gavoille, C.; Dubot, C.; Isambert, N.; Campone, M.; Tredan, O.; Massiani, M. A.; Mauborgne, C.; Armanet, S.; Servant, N.; Bieche, I.; Bernard, V.; Gentien, D.; Jezequel, P.; Attignon, V.; Boyault, S.; Vincent-Salomon, A.; Servois, V.; Sablin, M. P.; Kamal, M.; Paoletti, X.; investigators, Shiva
Mineralogy and uranium leaching of ores from Triassic Peribaltic sandstones journalArticle 2015 Gajda, D.; Kiegiel, K.; Zakrzewska-Koltuniewicz, G.; Chajduk, E.; Bartosiewicz, I.; Wolkowicz, S.
Equal access to innovative therapies and precision cancer care journalArticle 2016 Buzyn, A.; Blay, J. Y.; Hoog-Labouret, N.; Jimenez, M.; Nowak, F.; Deley, M. C.; Perol, D.; Cailliot, C.; Raynaud, J.; Vassal, G.
A new approach to integrate toxicity grade and repeated treatment cycles in the analysis and reporting of phase I dose-finding trials journalArticle 2015 Doussau, A.; Thiebaut, R.; Geoerger, B.; Schoffski, P.; Floquet, A.; Le Deley, M. C.; Mathoulin-Pelissier, S.; Rizzo, E.; Fumoleau, P.; Le Tourneau, C.; Paoletti, X.
Outcome after ablation in patients with low-risk thyroid cancer (ESTIMABL1): 5-year follow-up results of a randomised, phase 3, equivalence trial journalArticle 2018 Schlumberger, M.; Leboulleux, S.; Catargi, B.; Deandreis, D.; Zerdoud, S.; Bardet, S.; Rusu, D.; Godbert, Y.; Buffet, C.; Schvartz, C.; Vera, P.; Morel, O.; Benisvy, D.; Bournaud, C.; Toubert, M. E.; Kelly, A.; Benhamou, E.; Borget, I.
[Post-treatment follow-up of head and neck cancer patients] journalArticle 2019 Graff, P.; Blanchard, P.; Thariat, J.; Racadot, S.; Lapeyre, M.
Risk of Subsequent Leukemia After a Solid Tumor in Childhood: Impact of Bone Marrow Radiation Therapy and Chemotherapy journalArticle 2015 Allodji, R. S.; Schwartz, B.; Veres, C.; Haddy, N.; Rubino, C.; Le Deley, M. C.; Labbé, M.; Diop, F.; Jackson, A.; Dayet, F.; Benabdennebi, A.; Llanas, D.; Vu Bezin, J.; Chavaudra, J.; Lefkopoulos, D.; Deutsch, E.; Oberlin, O.; de Vathaire, F.; Diallo, I.
Multiple recurrences and risk of disease progression in patients with primary low-grade (TaG1) non-muscle-invasive bladder cancer and with low and intermediate EORTC-risk score journalArticle 2019 Simon, M.; Bosset, P. O.; Rouanne, M.; Benhamou, S.; Radulescu, C.; Molinie, V.; Neuzillet, Y.; Paoletti, X.; Lebret, T.
[A randomized controlled trial of metastases-directed treatment in patients with metastatic prostate cancer using stereotactic body irradiation: A GETUG-AFU trial] journalArticle 2017 Blanchard, P.; Foulon, S.; Louvel, G.; Habibian, M.; Fizazi, K.
Precision medicine: lessons learned from the SHIVA trial - Authors' reply journalArticle 2015 Le Tourneau, C.; Belin, L.; Paoletti, X.; Bieche, I.; Kamal, M.
Nedaplatin in nasopharyngeal cancer: the rebirth of platinum salts? journalArticle 2018 Blanchard, P.; Tao, Y.
Looking Beyond the Numbers: Highlighting the Challenges of Population-Based Studies in Cancer Research journalArticle 2016 Blanchard, P.; Garden, A. S.
Outcome of and prognostic factors for relapse in children and adolescents with mature B-cell lymphoma and leukemia treated in three consecutive prospective "Lymphomes Malins B" protocols. A Société Française des Cancers de l'Enfant study journalArticle 2015 Jourdain, A.; Auperin, A.; Minard-Colin, V.; Aladjidi, N.; Zsiros, J.; Coze, C.; Gandemer, V.; Bertrand, Y.; Leverger, G.; Bergeron, C.; Michon, J.; Patte, C.
Mining the coding and non-coding genome for cancer drivers journalArticle 2015 Li, J.; Drubay, D.; Michiels, S.; Gautheret, D.
Sinonasal squamous cell carcinoma without clinical lymph node involvement : Which neck management is best? journalArticle 2016 Castelnau-Marchand, P.; Levy, A.; Moya-Plana, A.; Mirghani, H.; Nguyen, F.; Del Campo, E. R.; Janot, F.; Kolb, F.; Ferrand, F. R.; Temam, S.; Blanchard, P.; Tao, Y.
Adjuvant chemotherapy for resected early-stage non-small cell lung cancer journalArticle 2015 Burdett, S.; Pignon, J. P.; Tierney, J.; Tribodet, H.; Stewart, L.; Le Pechoux, C.; Aupérin, A.; Le Chevalier, T.; Stephens, R. J.; Arriagada, R.; Higgins, J. P.; Johnson, D. H.; Van Meerbeeck, J.; Parmar, M. K.; Souhami, R. L.; Bergman, B.; Douillard, J. Y.; Dunant, A.; Endo, C.; Girling, D.; Kato, H.; Keller, S. M.; Kimura, H.; Knuuttila, A.; Kodama, K.; Komaki, R.; Kris, M. G.; Lad, T.; Mineo, T.; Piantadosi, S.; Rosell, R.; Scagliotti, G.; Seymour, L. K.; Shepherd, F. A.; Sylvester, R.; Tada, H.; Tanaka, F.; Torri, V.; Waller, D.; Liang, Y.
Baseline gut microbiota predicts clinical response and colitis in metastatic melanoma patients treated with ipilimumab journalArticle 2017 Chaput, N.; Lepage, P.; Coutzac, C.; Soularue, E.; Le Roux, K.; Monot, C.; Boselli, L.; Routier, E.; Cassard, L.; Collins, M.; Vaysse, T.; Marthey, L.; Eggermont, A.; Asvatourian, V.; Lanoy, E.; Mateus, C.; Robert, C.; Carbonnel, F.
The protein phosphatase 2A regulatory subunit PR70 is a gonosomal melanoma tumor suppressor gene journalArticle 2016 van Kempen, L. C.; Redpath, M.; Elchebly, M.; Klein, K. O.; Papadakis, A. I.; Wilmott, J. S.; Scolyer, R. A.; Edqvist, P. H.; Ponten, F.; Schadendorf, D.; van Rijk, A. F.; Michiels, S.; Dumay, A.; Helbling-Leclerc, A.; Dessen, P.; Wouters, J.; Stass, M.; Greenwood, C. M.; Ghanem, G. E.; van den Oord, J.; Feunteun, J.; Spatz, A.
Prospective Phase 2 Trial of Permanent Seed Implantation Prostate Brachytherapy for Intermediate-Risk Localized Prostate Cancer: Efficacy, Toxicity, and Quality of Life Outcomes journalArticle 2018 Frank, S. J.; Pugh, T. J.; Blanchard, P.; Mahmood, U.; Graber, W. J.; Kudchadker, R. J.; Davis, J. W.; Kim, J.; Choi, H.; Troncoso, P.; Kuban, D. A.; Choi, S.; McGuire, S.; Hoffman, K. E.; Chen, H. C.; Wang, X.; Swanson, D. A.
Impact of missing individual patient data on 18 meta-analyses of randomised trials in oncology: Gustave Roussy experience journalArticle 2018 Fayard, F.; Petit, C.; Lacas, B.; Pignon, J. P.
High level of chromosomal instability in circulating tumor cells of ROS1-rearranged non-small-cell lung cancer journalArticle 2015 Pailler, E.; Auger, N.; Lindsay, C. R.; Vielh, P.; Islas-Morris-Hernandez, A.; Borget, I.; Ngo-Camus, M.; Planchard, D.; Soria, J. C.; Besse, B.; Farace, F.
Non-Hodgkin Lymphoma in Children and Adolescents: Progress Through Effective Collaboration, Current Knowledge, and Challenges Ahead journalArticle 2015 Minard-Colin, V.; Brugières, L.; Reiter, A.; Cairo, M. S.; Gross, T. G.; Woessmann, W.; Burkhardt, B.; Sandlund, J. T.; Williams, D.; Pillon, M.; Horibe, K.; Auperin, A.; Le Deley, M. C.; Zimmerman, M.; Perkins, S. L.; Raphael, M.; Lamant, L.; Klapper, W.; Mussolin, L.; Poirel, H. A.; Macintyre, E.; Damm-Welk, C.; Rosolen, A.; Patte, C.
Opioid-related genetic polymorphisms do not influence postoperative opioid requirement: A prospective observational study journalArticle 2018 Aubrun, F.; Zahr, N.; Langeron, O.; Boccheciampe, N.; Cozic, N.; Belin, L.; Hulot, J. S.; Khiami, F.; Riou, B.
Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials journalArticle 2015 Coleman, R.; Powles, T.; Paterson, A.; Gnant, M.; Anderson, S.; Diel, I.; Gralow, J.; von Minckwitz, G.; Moebus, V.; Bergh, J.; Pritchard, K. I.; Bliss, J.; Cameron, D.; Evans, V.; Pan, H.; Peto, R.; Bradley, R.; Gray, R.
Difference in Restricted Mean Survival Time for Cost-Effectiveness Analysis Using Individual Patient Data Meta-Analysis: Evidence from a Case Study journalArticle 2016 Lueza, B.; Mauguen, A.; Pignon, J. P.; Rivero-Arias, O.; Bonastre, J.; Group, Mar-Lc Collaborative
Statistical evaluation of surrogate endpoints with examples from cancer clinical trials journalArticle 2016 Buyse, M.; Molenberghs, G.; Paoletti, X.; Oba, K.; Alonso, A.; Van der Elst, W.; Burzykowski, T.
Systematic review and meta-analysis of phase I/II targeted therapy combined with radiotherapy in patients with glioblastoma multiforme: quality of report, toxicity, and survival journalArticle 2015 dos Santos, M. A.; Pignon, J. P.; Blanchard, P.; Lefeuvre, D.; Levy, A.; Touat, M.; Louvel, G.; Dhermain, F.; Soria, J. C.; Deutsch, E.; Le Teuff, G.
Leukocytosis, prognosis biomarker in locally advanced head and neck cancer patients after chemoradiotherapy journalArticle 2018 Schernberg, A.; Blanchard, P.; Chargari, C.; Ou, D.; Levy, A.; Gorphe, P.; Breuskin, I.; Atallah, S.; Caula, A.; Escande, A.; Janot, F.; Nguyen, F.; Temam, S.; Deutsch, E.; Tao, Y.
Smoking and papillomavirus DNA in patients with p16-positive N3 oropharyngeal squamous cell carcinoma journalArticle 2019 Gorphe, P.; Chekkoury Idrissi, Y.; Tao, Y.; Moya-Plana, A.; Casiraghi, O.; Janot, F.; Blanchard, P.; Mirghani, H.; Temam, S.
Modalités de surveillance des patients suivis pour un cancer de la prostate avancé : résultats d’une enquête nationale de pratique journalArticle 2016 Rozet, F.; Roupret, M.; Hennequin, C.; Massard, C.; Blanchard, P.; Le moulec, S.
The frequency of cancer in France: Most recent data and trends journalArticle 2017 Ribassin-Majed, L.; Le-Teuff, G.; Hill, C.
Modulation of Rb phosphorylation and antiproliferative response to palbociclib: the preoperative-palbociclib (POP) randomized clinical trial journalArticle 2018 Arnedos, M.; Bayar, M. A.; Cheaib, B.; Scott, V.; Bouakka, I.; Valent, A.; Adam, J.; Leroux-Kozal, V.; Marty, V.; Rapinat, A.; Mazouni, C.; Sarfati, B.; Bieche, I.; Balleyguier, C.; Gentien, D.; Delaloge, S.; Lacroix-Triki, M.; Michiels, S.; Andre, F.
Results and Survival of Locally Advanced AJCC 7th Edition T4a Laryngeal Squamous Cell Carcinoma Treated with Primary Total Laryngectomy and Postoperative Radiotherapy journalArticle 2016 Gorphe, P.; Matias, M.; Moya-Plana, A.; Tabarino, F.; Blanchard, P.; Tao, Y.; Janot, F.; Temam, S.
Author Correction: Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci journalArticle 2019 Schumacher, F. R.; Olama, A. A. A.; Berndt, S. I.; Benlloch, S.; Ahmed, M.; Saunders, E. J.; Dadaev, T.; Leongamornlert, D.; Anokian, E.; Cieza-Borrella, C.; Goh, C.; Brook, M. N.; Sheng, X.; Fachal, L.; Dennis, J.; Tyrer, J.; Muir, K.; Lophatananon, A.; Stevens, V. L.; Gapstur, S. M.; Carter, B. D.; Tangen, C. M.; Goodman, P. J.; Thompson, I. M., Jr.; Batra, J.; Chambers, S.; Moya, L.; Clements, J.; Horvath, L.; Tilley, W.; Risbridger, G. P.; Gronberg, H.; Aly, M.; Nordstrom, T.; Pharoah, P.; Pashayan, N.; Schleutker, J.; Tammela, T. L. J.; Sipeky, C.; Auvinen, A.; Albanes, D.; Weinstein, S.; Wolk, A.; Hakansson, N.; West, C. M. L.; Dunning, A. M.; Burnet, N.; Mucci, L. A.; Giovannucci, E.; Andriole, G. L.; Cussenot, O.; Cancel-Tassin, G.; Koutros, S.; Beane Freeman, L. E.; Sorensen, K. D.; Orntoft, T. F.; Borre, M.; Maehle, L.; Grindedal, E. M.; Neal, D. E.; Donovan, J. L.; Hamdy, F. C.; Martin, R. M.; Travis, R. C.; Key, T. J.; Hamilton, R. J.; Fleshner, N. E.; Finelli, A.; Ingles,
Quality of life after brachytherapy or bilateral nerve-sparing robot-assisted radical prostatectomy for prostate cancer: a prospective cohort journalArticle 2017 Blanchard, P.; Davis, J. W.; Frank, S. J.; Kim, J.; Pettaway, C. A.; Pugh, T. J.; Pisters, L. L.; Ward, J. F.; Choi, S.; Chapin, B. F.; Hoffman, K.; Navai, N.; Achim, M.; McGuire, S. E.; Matin, S. F.; Nguyen, Q.; Mahmood, U.; Graber, W. J.; Chen, H. C.; Wang, X.; Kuban, D. A.
Flexible modeling of disease activity measures improved prognosis of disability progression in relapsing-remitting multiple sclerosis journalArticle 2015 Le Teuff, G.; Abrahamowicz, M.; Wynant, W.; Binquet, C.; Moreau, T.; Quantin, C.
Patient-reported health-related quality of life for men treated with low-dose-rate prostate brachytherapy as monotherapy with 125-iodine, 103-palladium, or 131-cesium: Results of a prospective phase II study journalArticle 2018 Blanchard, P.; Pugh, T. J.; Swanson, D. A.; Mahmood, U.; Chen, H. C.; Wang, X.; Graber, W. J.; Kudchadker, R. J.; Bruno, T.; Feeley, T.; Frank, S. J.
Outcome According to Elective Pelvic Radiation Therapy in Patients With High-Risk Localized Prostate Cancer: A Secondary Analysis of the GETUG 12 Phase 3 Randomized Trial journalArticle 2016 Blanchard, P.; Faivre, L.; Lesaunier, F.; Salem, N.; Mesgouez-Nebout, N.; Deniau-Alexandre, E.; Rolland, F.; Ferrero, J. M.; Houede, N.; Mourey, L.; Theodore, C.; Krakowski, I.; Berdah, J. F.; Baciuchka, M.; Laguerre, B.; Davin, J. L.; Habibian, M.; Culine, S.; Laplanche, A.; Fizazi, K.
Predisposing factors of liver necrosis after transcatheter arterial chemoembolization in liver metastases from neuroendocrine tumor journalArticle 2015 Joskin, J.; de Baere, T.; Auperin, A.; Tselikas, L.; Guiu, B.; Farouil, G.; Boige, V.; Malka, D.; Leboulleux, S.; Ducreux, M.; Baudin, E.; Deschamps, F.
REBECA: a phase I study of bevacizumab and whole-brain radiation therapy for the treatment of brain metastasis from solid tumours journalArticle 2015 Levy, C.; Allouache, D.; Lacroix, J.; Dugue, A. E.; Supiot, S.; Campone, M.; Mahe, M.; Kichou, S.; Leheurteur, M.; Hanzen, C.; Dieras, V.; Kirova, Y.; Campana, F.; Le Rhun, E.; Gras, L.; Bachelot, T.; Sunyach, M. P.; Hrab, I.; Geffrelot, J.; Gunzer, K.; Constans, J. M.; Grellard, J. M.; Clarisse, B.; Paoletti, X.